Skip to main content

International Adaptation of NCCN Guidelines for Sub-Saharan Africa: Pediatric Acute Lymphoblastic Leukemia, Version 1.2025

In brief

NCCN adapts childhood leukemia guidance to varied resources across sub-Saharan Africa

The 2025 regional guidelines tailor recommendations for diagnosing, evaluating and treating children with acute lymphoblastic leukemia to sub-Saharan Africa's varied health care resources. They account for differences in available technologies, population metabolism and regulatory status, but this review describes recommendations rather than evidence that the adaptations improve patient outcomes.

Journal
Journal of the National Comprehensive Cancer Network : JNCCN (Q1)
Published
18 November 2026
Study design
Practice guideline / consensus
Evidence level
Level 1, High (CEBM 1c)
Authors
Hiroto Inaba, David Teachey, Daniel Hailu Kefenie, Haileyesus Endalew Adam, Ernest Adjei, Adeseye Michael Akinsete, et al.
PMID
43050780
DOI
10.6004/jnccn.2026.0059

Why clinicians should know about it

  • Picked for Hematology (top studies of the week, 22 November 2026): Regional clinical guidelines for pediatric acute lymphoblastic leukemia

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Acute Lymphoblastic Leukemia (ALL) include evidence-based, consensus-driven recommendations from a multidisciplinary panel of experts in the United States with knowledge and experience in the management of patients with pediatric ALL within maximal resource settings, such as those present at NCCN Member Institutions. The International Adaptations of the NCCN Guidelines address the availability of resources, metabolic differences in populations, and regulatory status of health care technologies used in cancer care in a specific country or region. These targeted regional resources are created to combat increasing cancer rates and provide treatment recommendations that are more specific and unique to each region or country. These resources are updated biennially; for the most current version, please go to http://www.nccn.org/global/what-we-do/international-adaptations. This manuscript reviews the recommendations outlined in the International Adaptation of NCCN Guidelines for Sub-Saharan Africa (SSA; referred to as NCCN Guidelines for SSA within this discussion), Version 1.2025, published August 11, 2025, for the optimal diagnosis, workup, and treatment of pediatric ALL within the variable resource settings of SSA while highlighting the modifications required to optimize care when the maximal resource settings provided at comprehensive cancer centers such as NCCN Member Institutions are not available.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.